TIMI Risk Score for STEMI: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{SI}} {{CMG}}; {{AE}} {{SSH}} ==Overview== ==TIMI Risk Score for STEMI== ===Calculation of the TIMI Risk Score for STEMI=== This handy calculator computes the 30 da..." |
m Bot: Removing from Primary care |
||
| (One intermediate revision by one other user not shown) | |||
| Line 10: | Line 10: | ||
{{#Widget:TIMI_STEMI}} | {{#Widget:TIMI_STEMI}} | ||
===Interpretation of the TIMI Risk Score for STEMI=== | ===Interpretation of the TIMI Risk Score for STEMI=== | ||
The interpretation of the score is as follows: | The interpretation of the score is as follows: | ||
| Line 24: | Line 25: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Medicine]] | [[Category:Medicine]] | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Up-To-Date]] | [[Category:Up-To-Date]] | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
[[Category:Calculator]] | [[Category:Calculator]] | ||
Latest revision as of 00:25, 30 July 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]
Overview
TIMI Risk Score for STEMI
Calculation of the TIMI Risk Score for STEMI
This handy calculator computes the 30 day mortality rate using TIMI risk score for STEMI.[1]
Check all boxes that apply to your patient:
Interpretation of the TIMI Risk Score for STEMI
The interpretation of the score is as follows:
- Score 0: 30 Day Mortality is 0.8%
- Score 1: 30 Day Mortality is 1.6%
- Score 2: 30 Day Mortality is 2.2%
- Score 3: 30 Day Mortality is 4.4%
- Score 4: 30 Day Mortality is 7.3%
- Score 5: 30 Day Mortality is 12.4%
- Score 6: 30 Day Mortality is 16.1%
- Score 7: 30 Day Mortality is 23.4%
- Score 8: 30 Day Mortality is 26.8%
- Score >8: 30 Day Mortality is 35.9%
References
- ↑ Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA; et al. (2000). "TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy". Circulation. 102 (17): 2031–7. PMID 11044416.